News
- All
- Asylia News
- Nirogy News
- Press Release
- Sporos News
- Stellanova News
- Tvardi News
JLABS @ TMC and Asylia Therapeutics on Navigating a Powerful Tool: The Human Immune System
February 17, 2021
Read More →
Tvardi Therapeutics Awarded “Most Promising” Company at the 2020 Texas Life Science Forum
December 28, 2020
Read More →
New Company Asylia Therapeutics Finalizes Exclusive Worldwide License Agreement
October 9, 2020
Read More →
Tvardi Therapeutics Announces Publication Demonstrating TTI-101 as a Therapeutic Option for Treatment-Resistant Breast Cancers
October 4, 2020
Read More →
Tvardi’s TTI-101 Receives $5 Million in Funding to Support Clinical Trials and Translational Research
June 24, 2020
Read More →
Heat Shock Protein-70 (HSP70) is an Essential Component of Anti-Tumor Immunity
May 2, 2020
Read More →